| 0078-0641 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0641 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0641 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0641 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0641 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0641 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0642 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0642 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0642 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0642 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0642 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0642 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0643 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0643 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0643 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0643 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0643 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0643 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0741 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0741 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0741 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0741 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0741 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0748 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0748 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0748 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0748 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0748 | Signifor LAR | pasireotide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 55292-139 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-139 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-139 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-140 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-140 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-140 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-141 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-141 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-141 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-142 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-142 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-142 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-143 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-143 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |
| 55292-143 | Signifor LAR | pasireotide | Recordati Rare Diseases Inc. | NDA | Current |